Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Nonhuman Primate
100%
Antibody-associated
100%
Mycobacterium Tuberculosis (M. tb)
100%
M. Tuberculosis Antigen
50%
Latent Tuberculosis Infection
37%
Active Tuberculosis
25%
Vaccine Development
25%
Airway
25%
Natural Infection
25%
Immunogenic
25%
Latent Infection
25%
Knowledge Gaps
25%
Early Immune Response
12%
Unbiased Approach
12%
Age of Infection
12%
Protective Antibodies
12%
Cellular Immunity
12%
Early Events
12%
Serial Sampling
12%
Disease Development
12%
Local Level
12%
Active Infection
12%
Immunologic Factors
12%
Protective Efficacy
12%
Humoral Immune Response
12%
Success Probability
12%
Host Factors
12%
Equal Ratios
12%
Tuberculosis Vaccine
12%
Latent Tuberculosis
12%
Cynomolgus Macaque
12%
Long-term Plan
12%
Monoclonal Antibody
12%
Efficacy in Vivo
12%
Macaque
12%
Bronchoalveolar Lavage Fluid
12%
Immunology and Microbiology
Infection
100%
Infectious Disease
90%
Antigen
40%
Airway
20%
Low Drug Dose
10%
Adoptive Immunity
10%
Macaca fascicularis
10%
Host Factor
10%
Bronchoalveolar Lavage Fluid
10%
Immune Response
10%
Blood Plasma
10%
BCG Vaccine
10%
Monoclonal Antibody
10%
Immunologic Factor
10%
Macaca
10%
Humoral Immunity
10%